Report
Laurent ALBIE
EUR 108.58 For Business Accounts Only

Short term view - SARTORIUS STEDIM BIOTECH : Prices are moving to the lower boundary of the rectangle.

The trend is still bearish, the invalidation level is above €62.50. The target is at €52.60.

Arguments :
- Prices are moving to the lower boundary of the rectangle.
Provider
Day By Day
Day By Day

​​DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.

Analysts
Laurent ALBIE

ResearchPool Subscriptions

Get the most out of your insights

Get in touch